Reuters logo
BRIEF-VBL Therapeutics announces fourth quarter 2016 financial results
March 27, 2017 / 11:45 AM / 6 months ago

BRIEF-VBL Therapeutics announces fourth quarter 2016 financial results

March 27 (Reuters) - Vascular Biogenics Ltd

* VBL Therapeutics announces fourth quarter and year end 2016 financial results

* Vascular Biogenics Ltd - at Dec 31, 2016, co had cash, cash equivalents and short-term bank deposits of $45.3 million and working capital of $41.8 million

* Vascular Biogenics- expects cash, cash equivalents,short-term bank deposits to fund operating expenses,capital expenditure requirements into 2019

* Vascular Biogenics Ltd - intends to operate and relocate to new site in Israel in second half of 2017

* Vascular Biogenics Ltd - “Intend to launch a phase 3 pivotal study in platinum-resistant ovarian cancer during second half of 2017” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below